作者
Philippe R. Bauer,Marlies Ostermann,Lene Russell,Chiara Robba,Sascha David,Bruno L. Ferreyro,Joan Cid,Pedro Castro,Nicole P. Juffermans,Luca Montini,Tasneem Pirani,Andry van de Louw,Nathan D. Nielsen,Julia Wendon,Anne Brignier,Miet Schetz,Jan T. Kielstein,Jeffrey L. Winters,Élie Azoulay,Nina Buchtele,Thomas Staudinger,Heinz Gisslinger,Gürkan Sengölge,Christian Zauner,Péter Jaksch,Karin Amrein,Peter Schellongowski,Thomas Staudinger,Anne‐Pascale Meert,Dominique Benoît,Fabio Silvio Taccone,Ana Paula Pierre de Moraes,William Viana,Guilliana Moralez,Thiago Lishoa,Márcio Soares,Jorge I. Salluh,Uenderson Alivad Oliveira da Silva,Sumech Shah,Sangeeta Mehta,Laveena Munshi,Balik Martin,Karvunidis Thomas,Kateřina Rusínová,Jonas Nelsen,Ann M. Moeller,Anders Perner,Sylvest Meyhoff,Ramin Brandt Bukan,Lene B. Nielsen,Docent Anne Kuitunen,Miia Valkonen,Antoine Rabbat,Isabelle Vinatier,Kada Klouche,Laura Platon,Xavier Monnet,Alexandre Demoule,Julien Mayaux,Akli Chermak,Caroline Lemaître,Élise Artaud-Macari,Élie Azoulay,Virginie Lemiale,Virginie Souppart,Michaël Darmon,Lara Zafrani,Sandrine Valade,Djamel Mokart,Benjamin Gaborit,Emmanuel Canet,Amélie Seguin,Sylvie Chevret,Nicolas Terzi,Carole Schwebel,Achille Kouatchet,Fabrice Bruneel,Frédéric Pène,Anne Moreau,Christophe Girault,François Barbier,Aisling McMahon,Brian Marsh,Ignacio Ayestarán,Gilda Cinnella,Antonella Cotoia,Massimo Antonelli,Luca Montini,Thomas Kaufmann,Dennis C. J. J. Bergmans,A. Man,Peter Pickkers,Pleun Hemelaar,Precious Pearl Landburg,Pål Klepstad,Andreas Barratt‐Due,Belén Encina,Val Hebron,Gabriel Moreno,Emilio Rodriguez Luis,Llorenç Socias Crespi,Jordi Rello,Victoria Metaxa,Hemang Yadav,Philippe R. Bauer,Andry van de Louw,Gastón Burghi
摘要
In this narrative review, we discuss the relevant issues of therapeutic plasma exchange (TPE) in critically ill patients. For many conditions, the optimal indication, device type, frequency, duration, type of replacement fluid and criteria for stopping TPE are uncertain. TPE is a potentially lifesaving but also invasive procedure with risk of adverse events and complications and requires close monitoring by experienced teams. In the intensive care unit (ICU), the indications for TPE can be divided into (1) absolute, well-established, and evidence-based, for which TPE is recognized as first-line therapy, (2) relative, for which TPE is a recognized second-line treatment (alone or combined) and (3) rescue therapy, where TPE is used with a limited or theoretical evidence base. New indications are emerging and ongoing knowledge gaps, notably regarding the use of TPE during critical illness, support the establishment of a TPE registry dedicated to intensive care medicine.